Ix Biopharma Ltd. (42C)
Market Closed
6 Oct, 09:00 AM
SGX SGX Primary S$
0. 55
-0.01
-1.8018%
S$
15.1M Market Cap
- P/E Ratio
- Div Yield
8.88M Volume
- Eps
S$ 0.56
Previous Close Want to track 42C and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ix Biopharma Ltd. (42C) Statistics
Valuation metrics
Market Cap 15.1M
Enterprise value 566.47M
Trailing P/E (ttm) -63.25
Forward P/E -
PEG ratio 1.91
Price/Sales (ttm) 83.96
Price/Book (mrq) 0.04
Enterprise Value/Revenue 82.66
Enterprise Value/EBITDA -61.59
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 12.29M
Average volume (90 days) 19.43M
Price summary
52-Week low 0.04
52-Week high 0.62
Beta -
50-Day moving average 0.54
200-Day moving average 0.42
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.17%
Operating margin -1.4%
Operational effectiveness
Return on assets -0.31%
Return on equity -0.82%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 6.5
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -7.59
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 13.98
Total debt (mrq) -
Total Debt/Equity (mrq) 0.38
Current ratio (mrq) 1.86%
Book value per share (mrq) 14.61
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
